Targeting the VEGF pathway has been identified as a promising technique for treating a range of cancers, such as renal cell carcinoma (44), gastric cancer (45), liver cancer (46) and HNSCC (47). Here, VEGFA is linked to head and neck squamous cell carcinoma.